{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T14:52:45Z","timestamp":1786114365774,"version":"build-2736575974"},"reference-count":40,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T00:00:00Z","timestamp":1778457600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000050","name":"National Heart Lung and Blood Institute","doi-asserted-by":"publisher","award":["R01HL163937"],"award-info":[{"award-number":["R01HL163937"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000968","name":"American Heart Association Inc","doi-asserted-by":"publisher","award":["20POST35200233"],"award-info":[{"award-number":["20POST35200233"]}],"id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014943","name":"Sarepta Therapeutics Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014943","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.ymthe.2026.04.030","type":"journal-article","created":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T23:28:01Z","timestamp":1778023681000},"page":"4502-4517","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["An RYR2-interacting fragment of MYBPC3 mitigates arrhythmia in human iPSC-CM and mouse models of CPVT"],"prefix":"10.1016","volume":"34","author":[{"given":"Fujian","family":"Lu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zexuan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaopeng","family":"Chi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiajin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Ponek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carter","family":"Liou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Durgesh","family":"Bonde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikoleta","family":"Pavlaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mason E.","family":"Sweat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanam","family":"Shafaattalab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yashasvi","family":"Tharani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maksymilian","family":"Prondzynski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vassilios J.","family":"Bezzerides","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4551-8079","authenticated-orcid":false,"given":"William T.","family":"Pu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymthe.2026.04.030_bib1","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/nrcardio.2012.93","article-title":"Inherited calcium channelopathies in the pathophysiology of arrhythmias","volume":"9","author":"Venetucci","year":"2012","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.ymthe.2026.04.030_bib2","doi-asserted-by":"crossref","first-page":"2592","DOI":"10.1016\/j.jacc.2020.12.073","article-title":"Precision medicine in catecholaminergic polymorphic ventricular tachycardia: JACC Focus Seminar 5\/5","volume":"77","author":"Priori","year":"2021","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ymthe.2026.04.030_bib3","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1007\/s12551-020-00729-x","article-title":"The architecture and function of cardiac dyads","volume":"12","author":"Lu","year":"2020","journal-title":"Biophys. Rev."},{"key":"10.1016\/j.ymthe.2026.04.030_bib4","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1161\/01.CIR.103.2.196","article-title":"Mutations in the cardiac ryanodine receptor gene (hRyR2) underlie catecholaminergic polymorphic ventricular tachycardia","volume":"103","author":"Priori","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.ymthe.2026.04.030_bib5","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1097\/HCO.0000000000001051","article-title":"Current management of inherited arrhythmia syndromes associated with the cardiac ryanodine receptor","volume":"38","author":"Przybylski","year":"2023","journal-title":"Curr. Opin. Cardiol."},{"key":"10.1016\/j.ymthe.2026.04.030_bib6","doi-asserted-by":"crossref","first-page":"2426","DOI":"10.1161\/CIRCULATIONAHA.108.829267","article-title":"Incidence and risk factors of arrhythmic events in catecholaminergic polymorphic ventricular tachycardia","volume":"119","author":"Hayashi","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.ymthe.2026.04.030_bib7","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1161\/CIRCEP.114.002217","article-title":"Catecholaminergic polymorphic ventricular tachycardia in children: analysis of therapeutic strategies and outcomes from an international multicenter registry","volume":"8","author":"Roston","year":"2015","journal-title":"Circ. Arrhythm. Electrophysiol."},{"key":"10.1016\/j.ymthe.2026.04.030_bib8","doi-asserted-by":"crossref","DOI":"10.1093\/europace\/euae044","article-title":"Insights into adherence to medication and lifestyle recommendations in an international cohort of patients with catecholaminergic polymorphic ventricular tachycardia","volume":"26","author":"Peltenburg","year":"2024","journal-title":"Europace."},{"key":"10.1016\/j.ymthe.2026.04.030_bib9","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abq7839","article-title":"An improved reporter identifies ruxolitinib as a potent and cardioprotective CaMKII inhibitor","volume":"15","author":"Reyes Gaido","year":"2023","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ymthe.2026.04.030_bib10","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1126\/science.1094301","article-title":"Protection from cardiac arrhythmia through ryanodine receptor-stabilizing protein calstabin2","volume":"304","author":"Wehrens","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.ymthe.2026.04.030_bib11","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1161\/CIRCULATIONAHA.118.038514","article-title":"Gene Therapy for Catecholaminergic Polymorphic Ventricular Tachycardia by Inhibition of Ca2+\/Calmodulin-Dependent Kinase II","volume":"140","author":"Bezzerides","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.ymthe.2026.04.030_bib12","doi-asserted-by":"crossref","DOI":"10.1093\/eurheartj\/ehad655.3135","article-title":"Overexpression of cardiac calsequestrin as a novel gene-therapy approach to treat CPVT1: in silico and in vivo proves of principle","volume":"44","author":"Santiago Castillo","year":"2023","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ymthe.2026.04.030_bib13","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1038\/s41467-022-29902-4","article-title":"CMYA5 establishes cardiac dyad architecture and positioning","volume":"13","author":"Lu","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2026.04.030_bib14","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.gene.2015.09.008","article-title":"Cardiac myosin-binding protein C (MYBPC3) in cardiac pathophysiology","volume":"573","author":"Carrier","year":"2015","journal-title":"Gene"},{"key":"10.1016\/j.ymthe.2026.04.030_bib15","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1038\/s41586-020-1947-z","article-title":"Mechanism of adrenergic CaV1","volume":"577","author":"Liu","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2026.04.030_bib16","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s12551-012-0067-x","article-title":"Cardiac myosin binding protein-C: redefining its structure and function","volume":"4","author":"Sadayappan","year":"2012","journal-title":"Biophys. Rev."},{"key":"10.1016\/j.ymthe.2026.04.030_bib17","article-title":"Association of cardiac myosin-binding protein-C with the ryanodine receptor channel - putative retrograde regulation?","volume":"131","author":"Stanczyk","year":"2018","journal-title":"J. Cel Sci."},{"key":"10.1016\/j.ymthe.2026.04.030_bib18","doi-asserted-by":"crossref","first-page":"5855","DOI":"10.1074\/jbc.M114.607911","article-title":"A hypertrophic cardiomyopathy-associated MYBPC3 mutation common in populations of South Asian descent causes contractile dysfunction","volume":"290","author":"Kuster","year":"2015","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ymthe.2026.04.030_bib19","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1038\/nbt0502-473","article-title":"Protein detection using proximity-dependent DNA ligation assays","volume":"20","author":"Fredriksson","year":"2002","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ymthe.2026.04.030_bib20","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1038\/s41467-021-21141-3","article-title":"Pathological conformations of disease mutant Ryanodine Receptors revealed by cryo-EM","volume":"12","author":"Woll","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2026.04.030_bib21","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1161\/CIRCULATIONAHA.125.075402","article-title":"Direct therapeutic modulation of RYR2 activity by CMYA5","volume":"152","author":"Lu","year":"2025","journal-title":"Circulation"},{"key":"10.1016\/j.ymthe.2026.04.030_bib22","doi-asserted-by":"crossref","first-page":"12179","DOI":"10.1073\/pnas.0600268103","article-title":"Mice with the R176Q cardiac ryanodine receptor mutation exhibit catecholamine-induced ventricular tachycardia and cardiomyopathy","volume":"103","author":"Kannankeril","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2026.04.030_bib23","doi-asserted-by":"crossref","first-page":"793","DOI":"10.2144\/000113519","article-title":"An improved bimolecular fluorescence complementation assay with a high signal-to-noise ratio","volume":"49","author":"Kodama","year":"2010","journal-title":"Biotechniques"},{"key":"10.1016\/j.ymthe.2026.04.030_bib24","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1038\/ng.309","article-title":"A common MYBPC3 (cardiac myosin binding protein C) variant associated with cardiomyopathies in South Asia","volume":"41","author":"Dhandapany","year":"2009","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ymthe.2026.04.030_bib25","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1161\/CIRCULATIONAHA.119.039711","article-title":"Insights Into the Pathogenesis of Catecholaminergic Polymorphic Ventricular Tachycardia From Engineered Human Heart Tissue","volume":"140","author":"Park","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.ymthe.2026.04.030_bib26","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/j.cell.2025.01.011","article-title":"Advances in the study and treatment of genetic cardiomyopathies","volume":"188","author":"Parikh","year":"2025","journal-title":"Cell"},{"key":"10.1016\/j.ymthe.2026.04.030_bib27","doi-asserted-by":"crossref","first-page":"2196","DOI":"10.1038\/s41467-025-57481-7","article-title":"AAV9-mediated MYBPC3 gene therapy with optimized expression cassette enhances cardiac function and survival in MYBPC3 cardiomyopathy models","volume":"16","author":"Greer-Short","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2026.04.030_bib28","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.yjmcc.2010.10.001","article-title":"Calmodulin kinase II inhibition prevents arrhythmias in RyR2(R4496C+\/-) mice with catecholaminergic polymorphic ventricular tachycardia","volume":"50","author":"Liu","year":"2011","journal-title":"J. Mol. Cel. Cardiol."},{"key":"10.1016\/j.ymthe.2026.04.030_bib29","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aba7287","article-title":"Cardiac ryanodine receptor calcium release deficiency syndrome","volume":"13","author":"Sun","year":"2021","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ymthe.2026.04.030_bib30","doi-asserted-by":"crossref","DOI":"10.1172\/JCI162891","article-title":"Targeting ryanodine receptors to treat human diseases","volume":"133","author":"Marks","year":"2023","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ymthe.2026.04.030_bib31","doi-asserted-by":"crossref","first-page":"2425","DOI":"10.1016\/j.bbadis.2013.06.008","article-title":"Alterations in ryanodine receptors and related proteins in heart failure","volume":"1832","author":"Ather","year":"2013","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ymthe.2026.04.030_bib32","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1161\/CIRCEP.109.894683","article-title":"Sudden infant death syndrome in mice with an inherited mutation in RyR2","volume":"2","author":"Mathur","year":"2009","journal-title":"Circ. Arrhythm. Electrophysiol."},{"key":"10.1016\/j.ymthe.2026.04.030_bib33","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1038\/s41551-024-01253-z","article-title":"Virally delivered CMYA5 enhances the assembly of cardiac dyads","volume":"9","author":"Lu","year":"2025","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.ymthe.2026.04.030_bib34","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1161\/01.RES.0000192146.85173.4b","article-title":"Enhanced store overload-induced Ca2+ release and channel sensitivity to luminal Ca2+ activation are common defects of RyR2 mutations linked to ventricular tachycardia and sudden death","volume":"97","author":"Jiang","year":"2005","journal-title":"Circ. Res."},{"key":"10.1016\/j.ymthe.2026.04.030_bib35","first-page":"870","article-title":"CHELATOR: an improved method for computing metal ion concentrations in physiological solutions","volume":"12","author":"Schoenmakers","year":"1992","journal-title":"Biotechniques"},{"key":"10.1016\/j.ymthe.2026.04.030_bib36","doi-asserted-by":"crossref","first-page":"5929","DOI":"10.1038\/s41467-024-50224-0","article-title":"Efficient and reproducible generation of human iPSC-derived cardiomyocytes and cardiac organoids in stirred suspension systems","volume":"15","author":"Prondzynski","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2026.04.030_bib37","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/nprot.2016.152","article-title":"Efficient, footprint-free human iPSC genome editing by consolidation of Cas9\/CRISPR and piggyBac technologies","volume":"12","author":"Wang","year":"2017","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.ymthe.2026.04.030_bib38","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1161\/CIRCULATIONAHA.120.047784","article-title":"Imaging Sarcoplasmic Reticulum Ca2+ Signaling in Intact Cardiac Myocytes","volume":"142","author":"Lu","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.ymthe.2026.04.030_bib39","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1161\/CIRCRESAHA.114.302938","article-title":"Imaging Ca2+ nanosparks in heart with a new targeted biosensor","volume":"114","author":"Shang","year":"2014","journal-title":"Circ. Res."},{"key":"10.1016\/j.ymthe.2026.04.030_bib40","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1161\/CIRCRESAHA.123.322847","article-title":"SparkMaster 2: A new software for automatic analysis of calcium spark data","volume":"133","author":"Tomek","year":"2023","journal-title":"Circ. Res."}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001626002959?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001626002959?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T20:49:14Z","timestamp":1785962954000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001626002959"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":40,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["S1525001626002959"],"URL":"https:\/\/doi.org\/10.1016\/j.ymthe.2026.04.030","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"An RYR2-interacting fragment of MYBPC3 mitigates arrhythmia in human iPSC-CM and mouse models of CPVT","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymthe.2026.04.030","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc. on behalf of The American Society of Gene and Cell Therapy.","name":"copyright","label":"Copyright"}]}}